DK Life Science Co., Ltd. (KOSDAQ:303810)

Market Cap	95.31B -40.9%
Revenue (ttm)	130.34B -1.1%
Net Income	8.66B +285.7%
EPS	274.68 +243.3%
Shares Out	31.98M
PE Ratio	10.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	154,583
Average Volume	152,029
Open	3,010.00
Previous Close	2,980.00
Day's Range	2,990.00 - 3,050.00
52-Week Range	2,895.00 - 5,350.00
Beta	n/a
RSI	31.69
Earnings Date	n/a

About DK Life Science

DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments. The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software. DK Life Science Co., Ltd. was founded in 2017 and is based in Seoul, South Korea.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2017
• Employees: 100
• Stock Exchange: KOSDAQ
• Ticker Symbol: 303810

Financial Performance

In 2025, DK Life Science's revenue was 130.34 billion, a decrease of -1.12% compared to the previous year's 131.82 billion. Earnings were 8.66 billion, an increase of 285.71%.